Assessment of impaired vascular reactivity in a rat model of diabetic nephropathy: Effect of nitric oxide synthesis inhibition on intrarenal diffusion and oxygenation measured by magnetic resonance imaging

American Journal of Physiology - Renal Physiology

Volumn 305, Issue 10, 2013, Pages

  Hueper, Katja ^a,c   Hartung, Dagmar ^a,c   Gutberlet, Marcel ^a,c   Gueler, Faikah ^a   Sann, Holger ^b   Husen, Bettina ^b   Wacker, Frank ^a,c   Reiche, Dania ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b ABBOTT GMBH AND CO KG   (Germany)

^c Rebirth   (Germany)

Author keywords

Blood oxygen level dependent imaging; Diabetic nephropathy; Diffusion tensor imaging; N nitro L arginine methyle ester; Nitric oxide; Vascular reactivity

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BOLD SIGNAL; BOLUS INJECTION; CONDUCTANCE; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DIABETIC NEPHROPATHY; DIFFUSION TENSOR IMAGING; KIDNEY BLOOD VESSEL; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MEAN ARTERIAL PRESSURE; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RAT; RELAXATION TIME; TISSUE OXYGENATION; UNINEPHRECTOMY;

EID: 84887603956     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00123.2013     Document Type: Article

References (64)

1. 2 consumption, NOS, and Na/H exchange in diabetic rat proximal tubules. Am J Physiol Renal Physiol 283: F286-F293, 2002.
2. Broere A, Van Den Meiracker AH, Boomsma F, Derkx FH, Veld AJ, Schalekamp MA. Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME. Am J Physiol Renal Physiol 275: F870-F877, 1998.
3. Brown GC, Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 356: 295-298, 1994.
4. Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME, Russell G, Mauer M. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 51: 506-513, 2002.
5. Chrysochou C, Mendichovszky IA, Buckley DL, Cheung CM, Jackson A, Kalra PA. BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease. Nephrol Dial Transplant 27: 1013-1019, 2012.
6. Cipriani P, Kim SL, Klein JD, Sim JH, von Bergen TN, Blount MA. The role of nitric oxide in the dysregulation of the urine concentration mechanism in diabetes mellitus. Front Physiol 3: 176, 2012.
7. Dalla Vestra M, Saller A, Bortoloso E, Mauer M, Fioretto P. Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab 26, Suppl 4: 8-14, 2000.
8. Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir MR. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 28: 127-132, 1996.
9. dos Santos EA, Li LP, Ji L, Prasad PV. Early changes with diabetes in renal medullary hemodynamics as evaluated by fiberoptic probes and BOLD magnetic resonance imaging. Invest Radiol 42: 157-162, 2007.
10. Epstein FH, Veves A, Prasad PV. Effect of diabetes on renal medullary oxygenation during water diuresis. Diabetes Care 25: 575-578, 2002.
11. ERA-EDTA Registry. ERA-EDTA Registry Annual Report 2009. Amsterdam, The Netherlands: Academic Medical Center, Department of Medical Informatics, 2011.
12. Evans RG, Gardiner BS, Smith DW, O'Connor PM. Methods for studying the physiology of kidney oxygenation. Clin Exp Pharmacol Physiol 35: 1405-1412, 2008.
13. Evans RG, Ince C, Joles JA, Smith DW, May CN, O'Connor PM, Gardiner BS. Haemodynamic influences on kidney oxygenation: the clinical implications of integrative physiology. Clin Exp Pharmacol Physiol 40: 106-122, 2012.
14. Feng M, Whitesall S, Zhang Y, Beibel M, D'Alecy L, DiPetrillo K. Validation of volume-pressure recording tail-cuff blood pressure measurements. Am J Hypertens 21: 1288-1291, 2008.
15. Hagmann P, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli R. Understanding diffusion MR imaging techniques: from scalar diffusionweighted imaging to diffusion tensor imaging and beyond. Radiographics 26, Suppl 1: S205-223, 2006.
16. Han F, Xiao W, Xu Y, Wu J, Wang Q, Wang H, Zhang M, Chen J. The significance of BOLD MRI in differentiation between renal transplant rejection and acute tubular necrosis. Nephrol Dial Transplant 23: 2666-2672, 2008.
17. Hansell P, Welch WJ, Blantz RC, Palm F. Determinants of kidney oxygen consumption and its relation to tissue oxygen tension in diabetes and hypertension. Clin Exp Pharmacol Physiol 40: 123-137, 2012.
18. Haynes WG, Hand MF, Dockrell ME, Eadington DW, Lee MR, Hussein Z, Benjamin N, Webb DJ. Physiological role of nitric oxide in regulation of renal function in humans. Am J Physiol Renal Physiol 272: F364-F371, 1997.
19. Haynes WG, Noon JP, Walker BR, Webb DJ. L-NMMA increases blood pressure in man. Lancet 342: 931-932, 1993.
20. Heusch P, Wittsack HJ, Kropil P, Blondin D, Quentin M, Klasen J, Pentang G, Antoch G, Lanzman RS. Impact of blood flow on diffusion coefficients of the human kidney: a time-resolved ECG-triggered diffusion-tensor imaging (DTI) study at 3T. J Magn Reson Imaging 37: 233-236, 2013.
21. Hueper K, Hartung D, Gutberlet M, Gueler F, Sann H, Husen B, Wacker F, Reiche D. Magnetic resonance diffusion tensor imaging for evaluation of histopathological changes in a rat model of diabetic nephropathy. Invest Radiol 47: 430-437, 2012.
22. 2 during acute normovolemic hemodilution. Am J Physiol Renal Physiol 292: F796-F803, 2007.
23. Koivisto A, Pittner J, Froelich M, Persson AE. Oxygen-dependent inhibition of respiration in isolated renal tubules by nitric oxide. Kidney Int 55: 2368-2375, 1999.
24. Komers R, Anderson S. Glomerular endothelial NOS (eNOS) expression in type 2 diabetic patients with nephropathy. Nephrol Dial Transplant 23: 3037-3038, 2008.
25. Komers R, Anderson S. Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 284: F1121-F1137, 2003.
26. Korner A, Eklof AC, Celsi G, Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 43: 629-633, 1994.
27. Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE; Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals. Part 2: blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension 45: 299-310, 2005.
28. Leong CL, Anderson WP, O'Connor PM, Evans RG. Evidence that renal arterial-venous oxygen shunting contributes to dynamic regulation of renal oxygenation. Am J Physiol Renal Physiol 292: F1726-F1733, 2007.
29. Li L, Storey P, Kim D, Li W, Prasad P. Kidneys in hypertensive rats show reduced response to nitric oxide synthase inhibition as evaluated by BOLD MRI. J Magn Reson Imaging 17: 671-675, 2003.
30. Li LP, Ji L, Santos EA, Dunkle E, Pierchala L, Prasad P. Effect of nitric oxide synthase inhibition on intrarenal oxygenation as evaluated by blood oxygenation level-dependent magnetic resonance imaging. Invest Radiol 44: 67-73, 2009.
31. Lopes GS, Lemos CC, Mandarim-De-Lacerda CA, Bregman R. Effect of unilateral nephrectomy on renal function of diabetic rats. Histol Histopathol 19: 1085-1088, 2004.
32. Lu L, Sedor JR, Gulani V, Schelling JR, O'Brien A, Flask CA, MacRae Dell K. Use of diffusion tensor MRI to identify early changes in diabetic nephropathy. Am J Nephrol 34: 476-482, 2011.
33. Michaely HJ, Metzger L, Haneder S, Hansmann J, Schoenberg SO, Attenberger UI. Renal BOLD-MRI does not reflect renal function in chronic kidney disease. Kidney Int 81: 684-689, 2012.
34. Mogensen CE. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 46: 201-206, 1986.
35. Mukherjee P, Berman JI, Chung SW, Hess CP, Henry RG. Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings. Am J Neuroradiol 29: 632-641, 2008.
36. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. U.S. Renal Data System, USRDS 2009 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, 2009.
37. Notohamiprodjo M, Glaser C, Herrmann KA, Dietrich O, Attenberger UI, Reiser MF, Schoenberg SO, Michaely HJ. Diffusion tensor imaging of the kidney with parallel imaging: initial clinical experience. Invest Radiol 43: 677-685, 2008.
38. Palm F, Buerk DG, Carlsson PO, Hansell P, Liss P. Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation. Diabetes 54: 3282-3287, 2005.
39. Pauling L, Coryell CD. The magnetic properties and structure of hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin. Proc Natl Acad Sci USA 22: 210-216, 1936.
40. Prasad P, Li LP, Halter S, Cabray J, Ye M, Batlle D. Evaluation of renal hypoxia in diabetic mice by BOLD MRI. Invest Radiol 45: 819-822, 2010.
41. Prasad PV. Evaluation of intra-renal oxygenation by BOLD MRI. Nephron Clin Pract 103: c58-65, 2006.
42. Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 94: 3271-3275, 1996.
43. Prasad PV, Priatna A, Spokes K, Epstein FH. Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy. J Magn Reson Imaging 13: 744-747, 2001.
44. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metab Clin Exp 49: 1390-1394, 2000.
45. Ries M, Basseau F, Tyndal B, Jones R, Deminiere C, Catargi B, Combe C, Moonen CW, Grenier N. Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging 17: 104-113, 2003.
46. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341: 1127-1133, 1999.
47. Rognant N, Guebre-Egziabher F, Bacchetta J, Janier M, Hiba B, Langlois JB, Gadet R, Laville M, Juillard L. Evolution of renal oxygen content measured by BOLD MRI downstream a chronic renal artery stenosis. Nephrol Dial Transplant 26: 1205-1210, 2011.
48. Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy-an 8-year prospective study. Kidney Int 41: 822-828, 1992.
49. Sander M, Chavoshan B, Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 33: 937-942, 1999.
50. Schnackenberg CG. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 282: R335-R342, 2002.
51. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52: 313-320, 2005.
52. Steffes MW, Brown DM, Mauer SM. Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 27: 35-41, 1978.
53. Tesch GH, Allen TJ. Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) 12: 261-266, 2007.
54. Thoeny HC, Zumstein D, Simon-Zoula S, Eisenberger U, De Keyzer F, Hofmann L, Vock P, Boesch C, Frey FJ, Vermathen P. Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology 241: 812-821, 2006.
55. Thomas SR. Kidney modeling and systems physiology. Wiley Interdiscip Rev Syst Biol Med 1: 172-190, 2009.
56. Togao O, Doi S, Kuro-o M, Masaki T, Yorioka N, Takahashi M. Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstruction. Radiology 255: 772-780, 2010.
57. Wang ZJ, Kumar R, Banerjee S, Hsu CY. Blood oxygen leveldependent (BOLD) MRI of diabetic nephropathy: preliminary experience. J Magn Reson Imaging 33: 655-660, 2011.
58. 2 and renal oxygen usage in the hypertensive rat kidney. Kidney Int 59: 230-237, 2001.
59. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053, 2004.
60. Wittsack HJ, Lanzman RS, Quentin M, Kuhlemann J, Klasen J, Pentang G, Riegger C, Antoch G, Blondin D. Temporally resolved electrocardiogram-triggered diffusion-weighted imaging of the human kidney: correlation between intravoxel incoherent motion parameters and renal blood flow at different time points of the cardiac cycle. Invest Radiol 47: 226-230, 2012.
61. Wolff SP. Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 49: 642-652, 1993.
62. Yin WJ, Liu F, Li XM, Yang L, Zhao S, Huang ZX, Huang YQ, Liu RB. Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI. Eur J Radiol 81: 1426-1431, 2012.
63. Zatz R, de Nucci G. Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol Renal Fluid Electrolyte Physiol 261: F360-F363, 1991.
64. Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, Breyer MD, Harris RC. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 17: 2664-2669, 2006.